Facts of Stivarga (Regorafenib)
Product: STIVARGA (regorafenib) tablets, oral
Initial U.S. Approval: 2012
Indication: metastatic colorectal cancer (CRC)
Strength: 40 mg film-coated tablets
Company Bayer HealthCare Pharmaceuticals Inc.
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Stivarga (Regorafenib)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Stivarga (Regorafenib) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Stivarga is?
STIVARAG is a kinase inhibitor indicated for the treatment of patients with:
- Metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an antiVEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.
- Locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.
- Hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.
What Regorafenib is?
Regorafenib (BAY 73-4506, commercial name Stivarga) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had 2 US approvals for advanced cancers.
Pharma Services and Drug Inquiries
Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.
Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.
Complete the form below to receive the no-obligation price quote.
Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.
All Trademarks and Brands that appear on the website belong to their respective owners and South Delhi Pharma does not lay any claim on them we only provide Information. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.